Buthionine Sulfoximine Clinical Trials

Paid Clinical Trials > Browse Categories > Medications / Interventions > Bb > Buthionine Sulfoximine

Buthionine Sulfoximine

All Categories Medications / Interventions » Bb » Buthionine Sulfoximine

N99-02: Melphalan and Buthionine Sulfoximine Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Children With Resistant or Recurrent Neuroblastoma

Condition: Neuroblastoma
Interventions: Drug: buthionine sulfoximine; Drug: melphalan; Procedure: Peripheral blood stem cell infusion; Other: Filgrastim
Sponsors: New Approaches to Neuroblastoma Therapy Consortium; New Approaches to Neuroblastoma Therapy Consortium; National Cancer Institute (NCI)
Recruiting - verified April 2012

Main Menu

Clinical Trial Categories

Clinical Trial Locations

Sponsors/Recruiting

Join Clinical Trials

Patient Accounts| Sponsor Accounts | Paid Cliical Trials | Find Patients | Clinical Trail Jobs | Articles |Privacy Policy | Email Policy | Terms of Use | HIPPA |Contact Us | Sitemap
All information is pulled by the U.S. National Library of Medicine,U.S. National Institutes of Health, U.S. Department of Health & Human Services. Note: PaidClinicalTrials.org, paidclinicaltrials.org (Aunica Media llc) are resources that provide individuals with information regarding clinical trials that are being conducted nationwide. Aunica Media llc does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating. And Ye shall know the truth, and the truth shall make you free